Scohia Pharma is a biotech firm that specializes in synthetic and pharmacology research, clinical development, and collaboration services.
Scohia Pharma has raised $442.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.
Scohia Pharma's investors include SBI Investment, Beyond Next Ventures, Takeda, KSP, DCI Partners.
Scohia Pharma is headquartered in Fujisawa, Japan.
Scohia Pharma is a biotech firm that specializes in synthetic and pharmacology research, clinical development, and collaboration services.
Scohia Pharma is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scohia Pharma — Funding & Investors." VCBacked, May 28, 2026, https://www.vcbacked.co/company/scohia-pharma. Accessed September 30, 2026.
VCBacked. (2026). Scohia Pharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/scohia-pharma
{{cite web |title=Scohia Pharma — Funding & Investors |url=https://www.vcbacked.co/company/scohia-pharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated